Advertisement

Ads Placeholder
Loading...

Sensorion SA

ALSEN.PAEURONEXT
Healthcare
Biotechnology
0.42
-0.01(-1.65%)
U.S. Market opens in 55h 44m

Sensorion SA Fundamental Analysis

Sensorion SA (ALSEN.PA) shows moderate financial fundamentals with a PE ratio of -4.27, profit margin of -12.65%, and ROE of -58.01%. The company generates $0.0B in annual revenue with strong year-over-year growth of 16.76%.

Key Strengths

Cash Position37.73%
Current Ratio4.59

Areas of Concern

ROE-58.01%
Operating Margin-15.71%
We analyze ALSEN.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -960.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-960.2/100

We analyze ALSEN.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALSEN.PA struggles to generate sufficient returns from assets.

ROA > 10%
-50.84%

Valuation Score

Excellent

ALSEN.PA trades at attractive valuation levels.

PE < 25
-4.27
PEG Ratio < 2
1.00

Growth Score

Excellent

ALSEN.PA delivers strong and consistent growth momentum.

Revenue Growth > 5%
16.76%
EPS Growth > 10%
46.18%

Financial Health Score

Excellent

ALSEN.PA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
4.59

Profitability Score

Weak

ALSEN.PA struggles to sustain strong margins.

ROE > 15%
-5801.28%
Net Margin ≥ 15%
-12.65%
Positive Free Cash Flow
No

Key Financial Metrics

Is ALSEN.PA Expensive or Cheap?

P/E Ratio

ALSEN.PA trades at -4.27 times earnings. This suggests potential undervaluation.

-4.27

PEG Ratio

When adjusting for growth, ALSEN.PA's PEG of 1.00 indicates fair valuation.

1.00

Price to Book

The market values Sensorion SA at 2.83 times its book value. This may indicate undervaluation.

2.83

EV/EBITDA

Enterprise value stands at -4.18 times EBITDA. This is generally considered low.

-4.18

How Well Does ALSEN.PA Make Money?

Net Profit Margin

For every $100 in sales, Sensorion SA keeps $-12.65 as profit after all expenses.

-12.65%

Operating Margin

Core operations generate -15.71 in profit for every $100 in revenue, before interest and taxes.

-15.71%

ROE

Management delivers $-58.01 in profit for every $100 of shareholder equity.

-58.01%

ROA

Sensorion SA generates $-50.84 in profit for every $100 in assets, demonstrating efficient asset deployment.

-50.84%

Following the Money - Real Cash Generation

Operating Cash Flow

Sensorion SA generates limited operating cash flow of $-27.85M, signaling weaker underlying cash strength.

$-27.85M

Free Cash Flow

Sensorion SA generates weak or negative free cash flow of $-28.11M, restricting financial flexibility.

$-28.11M

FCF Per Share

Each share generates $-0.09 in free cash annually.

$-0.09

FCF Yield

ALSEN.PA converts -21.61% of its market value into free cash.

-21.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.27

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.003

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.83

vs 25 benchmark

P/S Ratio

Price to sales ratio

54.97

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.59

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.58

vs 25 benchmark

ROA

Return on assets percentage

-0.51

vs 25 benchmark

ROCE

Return on capital employed

-0.80

vs 25 benchmark

How ALSEN.PA Stacks Against Its Sector Peers

MetricALSEN.PA ValueSector AveragePerformance
P/E Ratio-4.2728.45 Better (Cheaper)
ROE-58.01%763.00% Weak
Net Margin-1264.68%-45265.00% (disorted) Weak
Debt/Equity0.030.34 Strong (Low Leverage)
Current Ratio4.592795.60 Strong Liquidity
ROA-50.84%-16588.00% (disorted) Weak

ALSEN.PA outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sensorion SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-82.21%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

85.90%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

90.11%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ